Skip to main content

Peer Review reports

From: A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

Original Submission
14 Mar 2017 Submitted Original manuscript
26 May 2017 Author responded Author comments - Quentin Jacquinot
Resubmission - Version 2
26 May 2017 Submitted Manuscript version 2
9 Jun 2017 Editorially accepted
19 Jun 2017 Article published 10.1186/s12885-017-3420-4

You can find further information about peer review here.

Back to article page